Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-02

Clinical Trial Update: The Sustained Effects of Ketamine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating the sustained effects of ketamine for mental disorders was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Yale University | Conditions: Mental Disorders | Phase 1 | Status: TERMINATED | Results posted: 2020-07-02